Workflow
Shanghai Baolijia Chemical (301037)
icon
Search documents
保立佳(301037) - 独立董事工作制度(2025年4月)
2025-04-21 13:45
上海保立佳化工股份有限公司 独立董事工作制度 第一章 总 则 第一条 为进一步完善上海保立佳化工股份有限公司(以下简称"公司")治 理结构,切实保护中小股东及利益相关者的利益,促进公司规范运作,根据《中 华人民共和国公司法》(以下简称"《公司法》")、《中华人民共和国证券法》、 中国证券监督管理委员会(以下简称"中国证监会")制定的《上市公司独立董 事管理办法》(以下简称"《独立董事管理办法》")、深圳证券交易所(以下 简称"深交所")制定的《深圳证券交易所创业板股票上市规则》《深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《独立董事和 审计委员会履职手册》、中国上市公司协会制定的《上市公司独立董事履职指 引(2024 年修订)》(以下简称"《独立董事履职指引》")等法律、法规、 规范性文件的规定及《上海保立佳化工股份有限公司章程》(以下简称"《公司 章程》"),制定《上海保立佳化工股份有限公司独立董事工作制度》(以下简 称"本制度")。 第二条 独立董事是指不在公司担任除董事外的其他职务,并与其所受聘的 公司及其主要股东、实际控制人不存在直接或者间接利害关系,或者其他可能妨 碍其 ...
保立佳(301037) - 2024年度独立董事述职报告(卢雷)
2025-04-21 13:45
上海保立佳化工股份有限公司 2024 年度独立董事述职报告(卢雷) 尊敬的各位股东及股东代表: 本人卢雷作为上海保立佳化工股份有限公司(以下简称"公 司")的独立董事,严格按照《公司法》《证券法》《上市公司 独立董事管理办法》《公司章程》《独立董事工作制度》等相关 法律法规及公司内控制度的规定,在 2024 年的工作中本着客观、 独立的原则,认真履行独立董事职责,严格审议董事会各项议案, 促进公司规范化运作,维护了公司整体利益及全体股东的合法权 益。 现将本人 2024 年任职期间履职情况报告如下: 一、基本情况 (一)个人简历 卢雷先生,1979 年出生,中国国籍,无境外永久居留权, 本科学历,注册会计师、国际注册会计师。2000 年 7 月至 2013 年 9 月,任和信会计师事务所(特殊普通合伙)高级经理;2013 年 9 月至 2016 年 3 月,任利源好集团有限公司集团副总经理、 财务副总经理和董事会秘书;2016 年 3 月至 2019 年 5 月,任山 东富特能源管理股份有限公司集团副总经理、财务副总经理和董 事会秘书;2019 年 5 月至 2023 年 11 月,任青岛融茂兴业集团 有限公 ...
保立佳(301037) - 2024年度独立董事述职报告(刘树国)
2025-04-21 13:45
上海保立佳化工股份有限公司 2024 年度独立董事述职报告(刘树国) 尊敬的各位股东及股东代表: 本人刘树国作为上海保立佳化工股份有限公司(以下简称 "公司")的独立董事,本人在 2024 年度的工作中严格按照《公 司法》《证券法》《上市公司独立董事管理办法》等法律法规、 规范性文件和《公司章程》《独立董事工作制度》等公司规章制 度,积极出席相关会议,本着对全体股东尤其是中小股东负责的 态度,诚信、勤勉、独立地履行职责。 现将 2024 年度履职情况报告如下: 一、基本情况 (一)个人简历 本人刘树国,男,1979 年出生,中国国籍,无境外永久居 留权,本科学历,注册会计师、注册评估师、中级会计师。2002 年 7 月至 2005 年 3 月,任南车四方机车车辆股份有限公司财务 部材料会计;2005 年 3 月至 2008 年 3 月,任青岛四方川崎车辆 技术有限公司财务经理;2008 年 3 月至 2015 年 7 月,任中兴华 会计师事务所(特殊普通合伙)项目经理、高级经理;2015 年 7 月至今,任山东鑫海润邦医疗用品配送有限公司财务总监。2018 年 4 月至 2022 年 12 月,兼任赛轮集团股 ...
保立佳(301037) - 董事会对独董独立性评估的专项意见
2025-04-21 13:45
上海保立佳化工股份有限公司 2024 年董事会对独立董事独立性评估的专项报告 综上,独立董事不存在任何妨碍其进行独立客观判断的关系, 不存在影响独立董事独立性的情况,符合《上市公司独立董事管 理办法》等法律法规及《公司章程》中关于独立董事的任职资格 及独立性的要求。 上海保立佳化工股份有限公司 董 事 会 2025 年 4 月 21 日 根据《上市公司独立董事管理办法》《深圳证券交易所上市 公司自律监管指引第 2 号——创业板上市公司规范运作》的规定, 独立董事应当每年对独立性情况进行自查,并将自查情况提交董 事会。 基于此,上海保立佳化工股份有限公司(以下简称"公司") 董事会根据相关法律法规并结合独立董事出具的《独立董事独立 性自查报告》,就公司在任独立董事的独立性情况进行评估,出 具如下专项意见:经公司独立董事自查及董事会核查独立董事在 公司的履职情况,董事会认为公司全体独立董事均具备胜任独立 董事岗位的资格。独立董事及其配偶、父母、子女、主要社会关 系未在公司或公司附属企业任职,未在公司主要股东及其附属企 业任职,未与公司存在重大的持股关系,与公司以及主要股东之 间不存在重大业务往来关系或提供财务、法 ...
保立佳(301037) - 公司章程(2025年4月)
2025-04-21 13:45
上海保立佳化工股份有限公司 章 程 2025 年 4 月 | | | | 第一章 | 总 | 则 1 | | --- | --- | --- | | 第二章 | | 经营宗旨和范围 2 | | 第三章 | 股 | 份 2 | | 第一节 | | 股份发行 2 | | 第二节 | | 股份增减和回购 3 | | 第三节 | | 股份转让 4 | | 第四章 | | 股东和股东会 5 | | 第一节 | | 股东 5 | | 第二节 | | 控股股东、实际控制人 8 | | 第三节 | | 股东会的一般规定 9 | | 第四节 | | 股东会的召集 13 | | 第五节 | | 股东会的提案与通知 15 | | 第六节 | | 股东会的召开 18 | | 第七节 | | 股东会的表决和决议 21 | | 第五章 | | 董事和董事会 25 | | 第一节 | | 董事的一般规定 25 | | 第二节 | | 董事会 29 | | 第三节 | | 独立董事 35 | | 第六章 | | 高级管理人员 37 | | 第七章 | 监 | 事 会 40 | | 第一节 | | 监事 40 | | 第二节 | | 监事会 ...
保立佳:2024年报净利润-1.5亿 同比下降383.87%
Tong Hua Shun Cai Bao· 2025-04-21 13:27
Financial Performance - The company reported a basic earnings per share of -1.0752 yuan for 2024, a decrease of 383.45% compared to -0.2224 yuan in 2023 [1] - The net profit for 2024 was -1.5 billion yuan, a significant decline from -0.31 billion yuan in 2023, representing a 383.87% decrease [1] - The total revenue for 2024 was 21.51 billion yuan, down 5.2% from 22.69 billion yuan in 2023 [1] - The return on equity for 2024 was -20.80%, a drastic drop from -3.84% in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 1.6885 million shares, accounting for 33.83% of the circulating shares, with a decrease of 123.48 thousand shares compared to the previous period [2] - Shanghai Yuwei Investment Partnership holds 473.55 thousand shares, representing 9.49% of the total share capital, with no change [3] - Shenzhen Maoyuan Investment Co., Ltd. decreased its holdings by 3.87 thousand shares, now holding 202.24 thousand shares, which is 4.05% of the total [3] Dividend Policy - The company has decided not to distribute dividends or increase capital [3]
保立佳(301037) - 2024 Q4 - 年度财报
2025-04-21 13:20
Financial Performance - The company achieved a revenue of 2.151 billion RMB in 2024, representing a year-on-year decline of 5.23% due to fluctuations in raw material prices and intensified industry competition[5]. - The net profit attributable to shareholders for 2024 was -150 million RMB, indicating a loss for the year[5]. - The company's operating revenue for 2024 was ¥2,150,776,464.74, a decrease of 5.23% compared to ¥2,269,473,890.51 in 2023[25]. - The net profit attributable to shareholders for 2024 was -¥149,670,051.70, representing a decline of 378.23% from -¥31,296,789.06 in 2023[25]. - The net cash flow from operating activities for 2024 was -¥170,590,632.40, a significant decrease of 168.36% compared to ¥249,562,570.57 in 2023[25]. - The basic earnings per share for 2024 was -¥1.0752, down 383.45% from -¥0.2224 in 2023[25]. - The company reported a net loss of approximately ¥976,727.08 in 2024, compared to a profit of ¥576,669.68 in 2023, indicating a significant decline in financial performance[31]. Strategic Initiatives - The company plans to enhance profitability by adjusting sales strategies, optimizing the industrial chain layout, accelerating overseas capacity expansion, increasing R&D efforts, and promoting internal management reforms[7]. - Future development strategies and operational plans are subject to market conditions and uncertainties, and do not constitute a commitment to investors[7]. - The company aims to solidify its domestic market foundation and expand into overseas markets by 2025, with a strategic focus on achieving the vision of becoming "the world’s Baoli Jia"[108]. - The company is focusing on R&D to develop high-performance, environmentally friendly products, including low-carbon and special function emulsions, to meet evolving customer needs[113]. Market Position and Industry Outlook - The company maintains a strong competitive position in the acrylic emulsion sector, with advanced R&D capabilities and stable customer resources, indicating potential for future growth[6]. - The industry is expected to stabilize and improve in the future due to the gradual elimination of outdated capacity and the recovery of downstream industries and domestic demand[6]. - The construction sector accounts for approximately 74% of the total consumption of acrylic emulsions, highlighting its dominance in the market[37]. - The demand for water-based acrylic emulsions is projected to benefit from infrastructure investments, renovation of old residential areas, and the expansion of new application scenarios[41]. Research and Development - The company has 46 effective invention patents and 20 utility model patents, showcasing its strong innovation capabilities[51]. - The company is focusing on technological advancements in the production of high-performance coatings, including elastic and high-gloss coatings[37]. - The company is actively developing new products and technologies, including low-odor water-based acrylic emulsions and specialized coatings for various applications[54]. - The company has developed a low formaldehyde, formaldehyde-free acrylic emulsion system, which has excellent performance and is widely used in textile coating applications[55]. Environmental Compliance - The company has received multiple environmental management certifications, including a wastewater discharge permit for Yantai New Materials valid from January 2024 to January 2029[58]. - The company has complied with all relevant environmental protection laws and regulations since 2012[184]. - The company has achieved compliance with emission standards across various pollutants, including ammonia at 0.93 mg/Nm³ against a limit of 30 mg/Nm³, indicating no exceedance[186]. - The company has implemented various environmental protection policies and industry standards since 2015[184]. Risk Management - The company faces various risks, including safety and environmental risks, raw material price volatility, accounts receivable risks, talent shortages, and liquidity risks[7]. - The company has increased provisions for asset impairments, including receivables and inventory, to ensure prudent financial management[5]. - The company is addressing raw material price volatility risks by diversifying procurement channels and implementing dynamic inventory management strategies[120]. Corporate Governance - The company has a clear governance structure that complies with relevant laws and regulations, ensuring effective decision-making processes[128]. - The company has established an independent financial accounting system and internal control mechanisms, ensuring compliance with legal regulations and independent financial decision-making[139]. - The company has implemented a performance evaluation system linking the compensation of directors and senior management to their performance[132]. - The company has appointed independent directors and established a supervisory board to enhance corporate governance and accountability[144]. Employee Management - The total number of employees at the end of the reporting period is 463, with 52 in the parent company and 411 in major subsidiaries[165]. - The company implements a compensation system based on position, ability, and performance to enhance operational performance and attract talent[167]. - A training system is established based on a talent development plan, focusing on cultural, management, marketing, and production training[168]. Future Growth Plans - The company aims to enhance its market position by leveraging its advanced technology and production capacity to meet diverse customer needs[51]. - The company plans to expand its overseas market presence, particularly in Southeast Asia, leveraging its Malaysia factory and targeting countries along the "Belt and Road" initiative[111]. - The company is implementing smart manufacturing upgrades, with plans to enhance production efficiency and reduce delivery cycles to under 48 hours by 2025[117].
保立佳(301037) - 2025 Q1 - 季度财报
2025-04-21 13:20
Revenue Performance - Revenue for Q1 2025 was CNY 425,441,299.89, a decrease of 12.09% compared to CNY 483,956,273.87 in the same period last year[6]. - Total operating revenue decreased to ¥425,441,299.89 from ¥483,956,273.87, representing a decline of approximately 12%[22]. Profitability - Net profit attributable to shareholders improved to CNY -10,347,259.13, a 61.77% increase from CNY -27,062,758.85 year-over-year[6]. - Net profit for the period was a loss of ¥10,415,486.70, compared to a loss of ¥27,057,903.58 in the previous period, showing an improvement of approximately 61%[24]. - Basic and diluted earnings per share improved to CNY -0.0742, a 72.52% increase from CNY -0.27 in the same period last year[6]. - The company reported a basic and diluted earnings per share of -¥0.0742, compared to -¥0.27 in the previous period[24]. Cash Flow - Operating cash flow turned positive at CNY 67,232,746.84, a significant improvement of 163.94% from CNY -105,143,354.89 in the previous year[6]. - Net cash flow from operating activities was $67.23 million, a significant improvement from a net outflow of $105.14 million in the previous period[27]. - Cash flow from operating activities was ¥276,503,935.54, slightly down from ¥278,854,887.28 in the previous period[26]. - Cash inflow from operating activities totaled $280.28 million, slightly down from $281.93 million, showing a marginal decline of 0.6%[27]. Assets and Liabilities - Total assets increased by 1.74% to CNY 2,545,289,608.82 compared to CNY 2,501,761,483.54 at the end of the previous year[6]. - Total liabilities increased to ¥1,919,696,259.31 from ¥1,866,004,459.31, an increase of approximately 3%[21]. - Total equity attributable to shareholders decreased to ¥622,385,721.02 from ¥632,481,168.17, a decline of about 2%[21]. Cost Management - Total operating costs decreased to ¥438,013,247.21 from ¥509,312,519.25, a reduction of about 14%[23]. - The company is focusing on cost reduction strategies, as evidenced by the significant decrease in operating costs and R&D expenses[23]. - Research and development expenses decreased by 56.09% to CNY 6,798,076.07 from CNY 15,482,553.70 year-over-year[12]. - Cash paid to employees was $28.22 million, down from $46.47 million, representing a decrease of about 39%[27]. - Cash paid for taxes was $6.97 million, significantly lower than $21.64 million, indicating a reduction of approximately 68%[27]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 4,897[15]. - The largest shareholder, Yang Wenyu, holds 51.92% of the shares, totaling 72,424,660 shares[15]. - The total number of restricted shares held by Yang Wenyu is 72,424,660, with 54,318,495 shares released from restrictions during the period[17]. Financing Activities - The company reported a 317.42% increase in receivables financing, reaching CNY 104,762,191.31 compared to CNY 25,097,514.63 last year[11]. - Total cash inflow from financing activities was $414.94 million, compared to $441.32 million in the prior period, indicating a slight decrease of 6%[27]. - Cash received from loans was $348.94 million, compared to $441.32 million, indicating a decrease of about 21%[27].
保立佳(301037) - 关于为全资子公司提供担保的进展公告
2025-03-14 08:00
证券代码:301037 证券简称:保立佳 公告编号:2025-005 上海保立佳化工股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 特别风险提示: 上海保立佳化工股份有限公司(以下简称"公司")及控股子 公司最新提供的预计担保额度不超过 30.43 亿元,占公司最近一 期经审计净资产的 379.77%,其中为资产负债率超过 70%的担保 对象提供的担保额度不超过 18.74 亿元,占公司最近一期经审计 净资产的 233.88%,上述担保均为公司及子公司对合并报表范围 内公司提供的担保。敬请广大投资者充分关注担保风险。 一、担保情况概述 公司于 2024 年 4 月 24 日、2024 年 6 月 3 日分别召开第三 届董事会第二十七次会议、第三届监事会第二十一次会议和 2023 年年度股东大会,审议并通过《关于公司为子公司提供担保额度 预计的议案》。公司及子公司拟为合并报表范围内的子公司提供 担保,担保额度累计不超过人民币 30.43 亿元。上述担保额度的 有效期为自 2023 年年度股东大会审议通过之日起未来 ...
保立佳(301037) - 关于部分首次公开发行前已发行股份上市流通提示性公告
2025-02-13 11:46
证券代码:301037 证券简称:保立佳 公告编号:2025-004 上海保立佳化工股份有限公司 关于部分首次公开发行前已发行股份上市流通 提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: 1、本次上市流通的限售股份为上海保立佳化工股份有限公 司(以下简称"公司")首次公开发行前已发行的部分股份。本次 解除限售股东户数为 1 户,解除限售股份数量为 72,424,660 股, 占公司总股本的 51.9167%。 2、本次解除限售股份上市流通日期为 2025 年 2 月 18 日(星 期二)。 一、首次公开发行前已发行股份概况及上市后股本变动情况 (一)首次公开发行股份情况 根据中国证券监督管理委员会《关于同意上海保立佳化工股 份有限公司首次公开发行股票注册的批复》(证监许可〔2021〕 2055号),公司首次公开发行人民币普通股(A股)股票22,525,000 股,并于 2021 年 7 月 30 日在深圳证券交易所创业板上市。首次 公开发行股票完成后公司总股本为 90,100,000 股,其中有限售条 件流通股 68,741,023 股 ...